172673-20-0 (福沙吡坦,Fosaprepitant)

福沙吡坦;[3-[[(2R,3S)-2-[(1R)-1-[3,5-双(三氟甲基)苯基]乙氧基]-3-(4-氟苯基)-4-吗啉基]甲基]-2,5-二氢-5-氧代-1H-1,2,4-三唑-1-基]膦酸;fosaprepitant福沙吡坦;福沙吡坦标准品;福沙吡坦杂质;福沙匹坦;福沙匹坦二甲基葡胺;福沙匹坦二葡甲胺;福沙吡坦二葡甲胺;福沙匹坦 /福沙匹坦二葡甲胺;

Fosaprepitant;[3-[[(2R,3S)-2-[(1R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-2,5-dihydro-5-oxo-1H-1,2,4-triazol-1-yl]phosphonic acid;[5-[[(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholin-4-yl]methyl]-3-oxo-1H-1,2,4-triazol-2-yl]phosphonic acid;Fosaprepitant dimeglumine;Fosaprepitant (See also F727305);6L8OF9XRDC;Emend? IV;L-758,298;L758298;UNII-6L8OF9XRDC;MK-0517 (Fosaprepitant);[3-[[(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholin-4-yl]methyl]-5-oxo-2H-1,2,4-triazol-1-yl]phosphonic acid;P-[3-[[(2R,3S)-2-[(1R)-1-[3,5-Bis(trifluoroMethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-Morpholinyl]Methyl]-2,5-dihydro-5-oxo-1H-1,2,4-triazol-1-yl]phosphonic Acid;D-Glucitol, 1-deoxy-1-(MethylaMino)-, (3-(((2R,3S)-2-((1R)-1-(3,5-bis(trifluoroMethyl)phenyl)ethoxy)-3-(4-fluorophenyl)-4- Morpholinyl)Methyl)-2,5-dihydro-5-oxo-1H-1,2,4-triazol-1-yl)phosphonate (2:1);L 758298;L785,298;NS00006479;D10895;(3-(((2R,3S)-2-((1R)-1-(3,5-BIS(TRIFLUOROMETHYL)PHENYL)ETHOXY)-3-(4-FLUOROPHENYL)MORPHOLIN-4-YL)METHYL)-5-OXO-4,5-DIHYDRO-1H-1,2,4-TRIAZOL-1-YL)PHOSPHONIC ACID;Phosphonic acid, (3-(((2R,3S)-2-((1R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)-4-morpholinyl)methyl)-2,5-dihydro-5-oxo-1H-1,2,4-triazol-1-yl)-;AC-25507;Fosaprepitant [INN];BCP9000702;NCGC00390240-01;Q5473324;Phosphonic acid, (3-((2-(1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)-4-morpholinyl)methyl)-2,5-dihydro-5-oxo-1H-1,2,4-triazol-1-yl)-, (2R-(2alpha(R*),3alpha))-;172673-20-0;PHOSPHONIC ACID, (3-(((2R,3S)-2-((1R)-1-(3,5-BIS(TRIFLUOROMETHYL)PHENYL)ETHOXY)-3-(4-FLUOROPHENYL)-4-MORPHOLINYL)METHYL)-4,5-DIHYDRO-5-OXO-1H-1,2,4-TRIAZOL-1-YL)-;Emend for injection;NSC794608;fosaprepitantum;CS-1760;BARDROPHSZEBKC-OITMNORJSA-O;Fosaprepitant [INN:BAN];(3-{[(2R,3S)-2-{(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy}-3-(4-fluorophenyl)morpholin-4-yl]methyl}-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)phosphonic acid;FOSAPREPITANT [EMA EPAR];AKOS025149465;[3-[[(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholin-4-yl]methyl]-5-oxo-4H-1,2,4-triazol-1-yl]phosphonic acid;CHEBI:64321;AM84605;DTXSID801021651;fosaprepitant-dimeglumine;FOSAPREPITANT [WHO-DD];Fosaprepitant free acid;FOSAPREPITANT [MI];FOSAPREPITANT [VANDF];FOSAPREPITANT [MART.];NSC-794608;Ivemend;EN300-37158610;HY-14407;Fosaprepitant (INN);L-758298;DB06717;FOSAPREPITANT (MART.);SCHEMBL309491;L-785,298;GTPL7623;CHEMBL1199324;(3-{[(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholin-4-yl]methyl}-5-oxo-2,5-dihydro-1H-1,2,4-triazol-1-yl)phosphonic acid;L 785,298;MK-0517;BRD-K23848629-401-02-9;BRD-K23848629-401-03-7;BRD-K23848629-401-04-5;DA-73530;

BARDROPHSZEBKC-OITMNORJSA-N

1S/C23H22F7N4O6P/c1-12(14-8-15(22(25,26)27)10-16(9-14)23(28,29)30)40-20-19(13-2-4-17(24)5-3-13)33(6-7-39-20)11-18-31-21(35)34(32-18)41(36,37)38/h2-5,8-10,12,19-20H,6-7,11H2,1H3,(H,31,32,35)(H2,36,37,38)/t12-,19+,20-/m1/s1

P(N1C(NC(CN2CCO[C@@H]([C@@H]2C2C=CC(=CC=2)F)O[C@H](C)C2C=C(C(F)(F)F)C=C(C(F)(F)F)C=2)=N1)=O)(=O)(O)O